TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Comparative Study on Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparison Between Tacrolimus + MMF and Tacrolimus + Steroid
Brief Summary: The aim of this study is to compare immunosuppression protocol of tacrolimus + MMF with that of tacrolimus + steroid for preventing recurrence of hepatitis C after living donor liver transplantation.


Options:
A: Arm Label: Everolimus + reduced tacrolimus; Type: EXPERIMENTAL; Interventions: Drug: Tacrolimus (reduced tacrolimus), Drug: Everolimus (reduced tacrolimus), Drug: Corticosteroids | Arm Label: Tacrolimus elimination; Type: EXPERIMENTAL; Interventions: Drug: Tacrolimus (tacrolimus elimination), Drug: Everolimus (tacrolimus elimination), Drug: Corticosteroids | Arm Label: Tacrolimus control; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tacrolimus (tacrolimus control), Drug: Corticosteroids | Intervention Type: DRUG; Name: Tacrolimus (reduced tacrolimus); Assigned to Arm(s): Everolimus + reduced tacrolimus | Intervention Type: DRUG; Name: Tacrolimus (tacrolimus elimination); Assigned to Arm(s): Tacrolimus elimination | Intervention Type: DRUG; Name: Tacrolimus (tacrolimus control); Assigned to Arm(s): Tacrolimus control | Intervention Type: DRUG; Name: Everolimus (reduced tacrolimus); Assigned to Arm(s): Everolimus + reduced tacrolimus | Intervention Type: DRUG; Name: Everolimus (tacrolimus elimination); Assigned to Arm(s): Tacrolimus elimination | Intervention Type: DRUG; Name: Corticosteroids; Assigned to Arm(s): Everolimus + reduced tacrolimus, Tacrolimus control, Tacrolimus elimination
B: Arm Label: EVR/TAC; Type: EXPERIMENTAL; Interventions: Drug: Everolimus, Drug: Tacrolimus, Drug: Corticosteroids | Arm Label: TAC; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tacrolimus, Drug: Corticosteroids | Intervention Type: DRUG; Name: Everolimus; Assigned to Arm(s): EVR/TAC | Intervention Type: DRUG; Name: Tacrolimus; Assigned to Arm(s): EVR/TAC, TAC | Intervention Type: DRUG; Name: Corticosteroids; Assigned to Arm(s): EVR/TAC, TAC
C: Intervention Type: DRUG; Name: ATG (Fresenius Biotech); Assigned to Arm(s): N/A
D: Arm Label: 1 Drug:; Type: ACTIVE_COMPARATOR; Interventions: Drug: tacrolimus + steroid | Arm Label: 2 Drug:; Type: ACTIVE_COMPARATOR; Interventions: Drug: tacrolimus + mycophenolate mofetil | Intervention Type: DRUG; Name: tacrolimus + steroid; Assigned to Arm(s): 1 Drug: | Intervention Type: DRUG; Name: tacrolimus + mycophenolate mofetil; Assigned to Arm(s): 2 Drug:

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Intra-Aortic Balloon Counterpulsation in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock - The Prospective, Randomised IABP SHOCK Trial for Attenuation of Multi-Organ Dysfunction Syndrome
Brief Summary: The role of intra aortic balloon counterpulsation in patients experiencing acute myocardial infarction with shock is not established. We hypothesised that use of such a device would lead to improved outcomes in these patients.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Arm Label: Levosimendan; Type: EXPERIMENTAL; Interventions: Drug: Levosimendan | Intervention Type: DRUG; Name: Levosimendan; Assigned to Arm(s): Levosimendan | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: levosimendan | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo, | Intervention Type: DRUG; Name: levosimendan; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: placebo,; Assigned to Arm(s): 2
C: Arm Label: L; Type: EXPERIMENTAL; Interventions: Drug: levosimendan | Arm Label: P; Type: EXPERIMENTAL; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: levosimendan; Assigned to Arm(s): L | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): P
D: Intervention Type: DEVICE; Name: Intra-aortic balloon pump counterpulsation; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Intra-Aortic Balloon Counterpulsation in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock - The Prospective, Randomised IABP SHOCK Trial for Attenuation of Multi-Organ Dysfunction Syndrome
Brief Summary: The role of intra aortic balloon counterpulsation in patients experiencing acute myocardial infarction with shock is not established. We hypothesised that use of such a device would lead to improved outcomes in these patients.


Options:
A: Intervention Type: DEVICE; Name: Intra-aortic balloon pump counterpulsation; Assigned to Arm(s): N/A
B: Arm Label: Elective IABP Insertion; Type: EXPERIMENTAL; Interventions: Device: Intra-Aortic Balloon Pump | Arm Label: No Planned IABP Insertion; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Intra-Aortic Balloon Pump; Assigned to Arm(s): Elective IABP Insertion
C: Arm Label: Enoxaparin; Type: ACTIVE_COMPARATOR; Interventions: Drug: enoxaparin | Arm Label: Fondaparinux; Type: EXPERIMENTAL; Interventions: Drug: Fondaparinux | Intervention Type: DRUG; Name: Fondaparinux; Assigned to Arm(s): Fondaparinux | Intervention Type: DRUG; Name: enoxaparin; Assigned to Arm(s): Enoxaparin
D: Arm Label: Intraaortic balloon pump; Type: ACTIVE_COMPARATOR; Interventions: Device: Intraaortic balloon pump | Arm Label: No intraaortic balloon pump; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Intraaortic balloon pump; Assigned to Arm(s): Intraaortic balloon pump

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tetracycline (Doxycycline) In Patients With Large Acute Myocardial Infarction TO Prevent Left Ventricular Remodeling. TIPTOP Study
Brief Summary: The aim of the study is to assess the efficacy of an antibiotic treatment with tetracycline (doxycycline) in the early stage of large reperfused acute myocardial infarction (AMI), in preventing left ventricular (LV) remodeling.


Options:
A: Arm Label: Doxycycline; Type: EXPERIMENTAL; Interventions: Drug: Doxycycline | Arm Label: Standard Therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Current medical therapy for AMI | Intervention Type: DRUG; Name: Doxycycline; Assigned to Arm(s): Doxycycline | Intervention Type: DRUG; Name: Current medical therapy for AMI; Assigned to Arm(s): Standard Therapy
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sirolimus | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sirolimus | Arm Label: 3; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Sirolimus; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Sirolimus; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 3
C: Arm Label: Clarithromycin; Type: EXPERIMENTAL; Interventions: Drug: clarithromycin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: clarithromycin | Intervention Type: DRUG; Name: clarithromycin; Assigned to Arm(s): Clarithromycin, Placebo
D: Arm Label: erythromycin group; Type: N/A; Interventions: N/A | Arm Label: control group; Type: N/A; Interventions: N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy of Inspiratory Muscle Training on Inspiratory Capacity in Patients
Brief Summary: Hypothesis:benefits of inspiratory muscle strenght training with Respifit S decreases symptoms, disability or handicap of patients affected by COPD. The inspiratory fraction (inspiratory capacity IC/ total lung capacity TLC)may be functionally more representative than other traditional indices.


Options:
A: Arm Label: Inspiratory muscle training; Type: EXPERIMENTAL; Interventions: Other: Inspiratory Muscle training | Arm Label: Declining Inspiratory muscle training; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Inspiratory Muscle training; Assigned to Arm(s): Inspiratory muscle training
B: Arm Label: Inspiratory Muscle Training; Type: EXPERIMENTAL; Interventions: Procedure: Inspiratory Muscle Training | Arm Label: Sham IMT; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Inspiratory Muscle Training | Intervention Type: PROCEDURE; Name: Inspiratory Muscle Training; Assigned to Arm(s): Inspiratory Muscle Training, Sham IMT
C: Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: inspiratory pressure training group; Type: EXPERIMENTAL; Interventions: Device: inspiratory pressure training group | Arm Label: mixed training group; Type: EXPERIMENTAL; Interventions: Device: mixed training group | Intervention Type: DEVICE; Name: inspiratory pressure training group; Assigned to Arm(s): inspiratory pressure training group | Intervention Type: DEVICE; Name: mixed training group; Assigned to Arm(s): mixed training group
D: N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Empiric Antihelminthic Therapy Combined With Antimony in the Treatment of Cutaneous Leishmaniasis: A Randomized Controlled Trial in Subjects Co-Infected With Helminths and Leishmania Brasiliensis
Brief Summary: The purpose of this project is to investigate the efficacy of early, empiric anti-helminthic therapy combined with standard pentavalent antimony in the treatment of subjects co-infected with helminths and cutaneous leishmaniasis caused by L. brasiliensis. The study hypothesis is that early intervention with antihelminthic therapy will improve response rates to antimony in subjects with cutaneous leishmaniasis.


Options:
A: Intervention Type: DRUG; Name: Anti-helminthic; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: meglumine antimony; Assigned to Arm(s): N/A
B: Arm Label: Annual school-based deworming; Type: ACTIVE_COMPARATOR; Interventions: Drug: albendazole | Arm Label: Annual community-based deworming; Type: EXPERIMENTAL; Interventions: Drug: albendazole | Arm Label: Biannual; Type: EXPERIMENTAL; Interventions: Drug: albendazole | Intervention Type: DRUG; Name: albendazole; Assigned to Arm(s): Annual community-based deworming, Annual school-based deworming, Biannual
C: Arm Label: Deworming at 12 months of age; Type: EXPERIMENTAL; Interventions: Drug: Mebendazole, Other: Usual care | Arm Label: Deworming at 18 months of age; Type: EXPERIMENTAL; Interventions: Drug: Mebendazole, Other: Usual care | Arm Label: Deworming at 12 and 18 months of age; Type: EXPERIMENTAL; Interventions: Drug: Mebendazole, Other: Usual care | Arm Label: Usual care; Type: PLACEBO_COMPARATOR; Interventions: Other: Usual care | Intervention Type: DRUG; Name: Mebendazole; Assigned to Arm(s): Deworming at 12 and 18 months of age, Deworming at 12 months of age, Deworming at 18 months of age | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Deworming at 12 and 18 months of age, Deworming at 12 months of age, Deworming at 18 months of age, Usual care
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Albendazole, Drug: Praziquantel | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Current standard of care in Kenya | Intervention Type: DRUG; Name: Albendazole; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Praziquantel; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Current standard of care in Kenya; Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Empiric Antihelminthic Therapy Combined With Antimony in the Treatment of Cutaneous Leishmaniasis: A Randomized Controlled Trial in Subjects Co-Infected With Helminths and Leishmania Brasiliensis
Brief Summary: The purpose of this project is to investigate the efficacy of early, empiric anti-helminthic therapy combined with standard pentavalent antimony in the treatment of subjects co-infected with helminths and cutaneous leishmaniasis caused by L. brasiliensis. The study hypothesis is that early intervention with antihelminthic therapy will improve response rates to antimony in subjects with cutaneous leishmaniasis.


Options:
A: Intervention Type: DRUG; Name: Anti-helminthic; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: meglumine antimony; Assigned to Arm(s): N/A
B: Arm Label: Topical Amphotericin B three times per day; Type: EXPERIMENTAL; Interventions: Drug: Topical Amphotericin B at 3% | Arm Label: Topical Amphotericin B two times per day; Type: EXPERIMENTAL; Interventions: Drug: Topical Amphotericin B at 3% | Intervention Type: DRUG; Name: Topical Amphotericin B at 3%; Assigned to Arm(s): Topical Amphotericin B three times per day, Topical Amphotericin B two times per day
C: Arm Label: High dose; Type: ACTIVE_COMPARATOR; Interventions: Drug: Meglumine antimoniate | Arm Label: Low dose; Type: EXPERIMENTAL; Interventions: Drug: Meglumine antimoniate | Intervention Type: DRUG; Name: Meglumine antimoniate; Assigned to Arm(s): High dose, Low dose
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: meglumine antimoniate | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: controlled nitric oxide releasing patch | Intervention Type: DRUG; Name: controlled nitric oxide releasing patch; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: meglumine antimoniate; Assigned to Arm(s): 1

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Exercise Training After Percutaneous Coronary Intervention
Brief Summary: The Efector study is an open, randomized and controlled trial assessing the effect of regular exercise training on endothelial function, inflammatory markers, progression of disease, heart rate variability and mental health in patients who have been successfully treated with percutaneous coronary intervention and stent implantation for angina pectoris.


Options:
A: Arm Label: Exercise; Type: EXPERIMENTAL; Interventions: Other: Exercise, Other: Cardiovascular Risk Factors | Arm Label: Exercise afther Microcurrent; Type: EXPERIMENTAL; Interventions: Other: Exercise, Device: Microcurrent, Other: Cardiovascular Risk Factors | Arm Label: Cardiovascular Risk Factors; Type: OTHER; Interventions: Other: Cardiovascular Risk Factors | Intervention Type: OTHER; Name: Exercise; Assigned to Arm(s): Exercise, Exercise afther Microcurrent | Intervention Type: DEVICE; Name: Microcurrent; Assigned to Arm(s): Exercise afther Microcurrent | Intervention Type: OTHER; Name: Cardiovascular Risk Factors; Assigned to Arm(s): Cardiovascular Risk Factors, Exercise, Exercise afther Microcurrent
B: Arm Label: Extended behavioral intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Extended behavioral intervention | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Extended behavioral intervention; Assigned to Arm(s): Extended behavioral intervention
C: Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Prehab Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Prehab Intervention | Intervention Type: BEHAVIORAL; Name: Prehab Intervention; Assigned to Arm(s): Prehab Intervention
D: Intervention Type: BEHAVIORAL; Name: exercise training; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Exercise Training After Percutaneous Coronary Intervention
Brief Summary: The Efector study is an open, randomized and controlled trial assessing the effect of regular exercise training on endothelial function, inflammatory markers, progression of disease, heart rate variability and mental health in patients who have been successfully treated with percutaneous coronary intervention and stent implantation for angina pectoris.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Rehabilitation in institution | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Rehabilitation at home, Behavioral: Out-patient rehabilitation at the hospital | Intervention Type: BEHAVIORAL; Name: Rehabilitation in institution; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Rehabilitation at home; Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: Out-patient rehabilitation at the hospital; Assigned to Arm(s): 2
B: Intervention Type: BEHAVIORAL; Name: multifactorial continued educational - behavioural programme; Assigned to Arm(s): N/A
C: Arm Label: Weight Loss; Type: EXPERIMENTAL; Interventions: Other: Weight Loss | Arm Label: Interval Training; Type: EXPERIMENTAL; Interventions: Other: Interval Training | Intervention Type: OTHER; Name: Interval Training; Assigned to Arm(s): Interval Training | Intervention Type: OTHER; Name: Weight Loss; Assigned to Arm(s): Weight Loss
D: Intervention Type: BEHAVIORAL; Name: exercise training; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Exercise Diet and Sex Hormones in Postmenopausal Women (NEW)
Brief Summary: RATIONALE: A low-calorie diet and/or exercise program may help lower an overweight or obese postmenopausal woman's risk of developing breast cancer. It is not yet known whether a low-calorie diet and/or exercise program are more effective than no diet or exercise program in lowering an overweight or obese postmenopausal woman's risk of developing breast cancer.

PURPOSE: This randomized clinical trial is studying the effect of a low-calorie diet and/or exercise program on risk factors for developing breast cancer compared with no diet or exercise program in overweight or obese postmenopausal women.


Options:
A: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Other: Weight loss intervention | Arm Label: Control Group (delayed intervention); Type: EXPERIMENTAL; Interventions: Other: Weight loss intervention | Intervention Type: OTHER; Name: Weight loss intervention; Assigned to Arm(s): Control Group (delayed intervention), Intervention Group
B: Intervention Type: BEHAVIORAL; Name: Weight reduction, Resistance training, Aerobic exercise training, Control; Assigned to Arm(s): N/A
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Caloric Restriction; Type: OTHER; Interventions: Behavioral: behavioral dietary intervention | Arm Label: Exercise Intervention; Type: OTHER; Interventions: Behavioral: Exercise intervention | Arm Label: Caloric Restriction AND Exercise Intervention; Type: OTHER; Interventions: Behavioral: behavioral dietary intervention, Behavioral: Exercise intervention | Intervention Type: BEHAVIORAL; Name: behavioral dietary intervention; Assigned to Arm(s): Caloric Restriction, Caloric Restriction AND Exercise Intervention | Intervention Type: BEHAVIORAL; Name: Exercise intervention; Assigned to Arm(s): Caloric Restriction AND Exercise Intervention, Exercise Intervention
D: Intervention Type: BEHAVIORAL; Name: diet, sodium-restricted; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: diet, fat-restricted; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: exercise; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: diet, reducing; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: alcohol drinking; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Exercise Diet and Sex Hormones in Postmenopausal Women (NEW)
Brief Summary: RATIONALE: A low-calorie diet and/or exercise program may help lower an overweight or obese postmenopausal woman's risk of developing breast cancer. It is not yet known whether a low-calorie diet and/or exercise program are more effective than no diet or exercise program in lowering an overweight or obese postmenopausal woman's risk of developing breast cancer.

PURPOSE: This randomized clinical trial is studying the effect of a low-calorie diet and/or exercise program on risk factors for developing breast cancer compared with no diet or exercise program in overweight or obese postmenopausal women.


Options:
A: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Other: Weight loss intervention | Arm Label: Control Group (delayed intervention); Type: EXPERIMENTAL; Interventions: Other: Weight loss intervention | Intervention Type: OTHER; Name: Weight loss intervention; Assigned to Arm(s): Control Group (delayed intervention), Intervention Group
B: Arm Label: Healthy Choices; Type: OTHER; Interventions: Behavioral: Healthy Choices | Arm Label: Diet Substitution A; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary substitution A | Arm Label: Diet Substitution B; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary Substitution B | Intervention Type: BEHAVIORAL; Name: Dietary substitution A; Assigned to Arm(s): Diet Substitution A | Intervention Type: BEHAVIORAL; Name: Dietary Substitution B; Assigned to Arm(s): Diet Substitution B | Intervention Type: BEHAVIORAL; Name: Healthy Choices; Assigned to Arm(s): Healthy Choices
C: Intervention Type: BEHAVIORAL; Name: diet, sodium-restricted; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: diet, fat-restricted; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: exercise; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: diet, reducing; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: alcohol drinking; Assigned to Arm(s): N/A
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Caloric Restriction; Type: OTHER; Interventions: Behavioral: behavioral dietary intervention | Arm Label: Exercise Intervention; Type: OTHER; Interventions: Behavioral: Exercise intervention | Arm Label: Caloric Restriction AND Exercise Intervention; Type: OTHER; Interventions: Behavioral: behavioral dietary intervention, Behavioral: Exercise intervention | Intervention Type: BEHAVIORAL; Name: behavioral dietary intervention; Assigned to Arm(s): Caloric Restriction, Caloric Restriction AND Exercise Intervention | Intervention Type: BEHAVIORAL; Name: Exercise intervention; Assigned to Arm(s): Caloric Restriction AND Exercise Intervention, Exercise Intervention

Answer: D